2025 / 04 / 04
Exhibition and Presentation at
CPHI Japan 2025
Ajinomoto Bio-Pharma Services will participate in CPHI Japan, on April 9 to 11, 2025.
CPHI Japan is the ideal business platform for international pharma professionals to join in order to grow their business in the rapidly evolving Japanese pharma market. Hosting over 420 exhibitors from ingredients, contract services and biopharma through to technology, packaging and machinery.
At the exhibition booth, the latest technologies and services such as AJIPHASE®, AJICAP®, CORYNEX®, and Gene therapy will be introduced.
In addition, the latest technologies and services of Forge Biologics (a gene therapy CDMO,) Gene Design (an oligonucleic acid CDMO), and CORYNEX® (a microbial platform for peptides/proteins) will be presented at the Biopharma Seminar.
We look forward to your visit.
| Event Name | CPHI Japan 2025 |
|---|---|
| Dates | April 9(Wed) – 11 (Fri), 2025 |
| Venue | Tokyo Big Sight |
| Exhibition | Booth : Bio Pharma 4V-08 Biopharma Seminar |
Biopharma Seminar
| Title and Presenters | “How Forge Biologics is improving the accessibility of genetic medicines through better manufacturing” Kazuo yamagishi, AJINOMOTO HEALTHY SUPPLY CO., INC. |
|---|---|
| Executive Summary | Forge Biologics has built a company focused on providing end-to-end manufacturing services for Recombinant adeno-associated virus (rAAV) gene therapies utilizing a transient plasmid transfection process. In this seminar, we will describe how Forge is improving the accessibility of genetic medicines through better manufacturing by making molecular improvements, process improvements, building enhanced analytics, scaling up our reactors and purification systems, scaling out our facility to increase the number of cGMP suites, and providing integrated regulatory support. In 2023, Forge joined Ajinomoto Group, a global business investing in our long-term growth and vision of providing hope to patients suffering from genetic diseases. In this presentation, we will introduce our one-stop-shop service from strain development to GMP manufacturing for client needs using our proprietary technologies. |
| Date, Time and Venue | April 9(Wed.)13:50-14:20 【Seminar Room 5A(East Hall5)／Seminar Room C8(608, Conference Tower)】 |
Biopharma Seminar
| Title and Presenters | “Ajinomoto Bio-Pharma Services, GeneDesign Efforts Towards Diversifying Nucleic Acid Medicine Modalities” Hideo Nakata, Ajinomoto Bio-Pharma Services, GeneDesign, Inc. |
|---|---|
| Executive Summary | Nucleic acid medicines are being actively developed worldwide, and as development progresses, their functions and structures are diversifying. At Ajinomoto Bio-Pharma Services, GeneDesign, as an oligonucleotide CDMO, we are undertaking various initiatives to accommodate these diverse modalities. In this seminar, we will introduce some of these efforts, including the synthesis of siRNA and long-chain RNA using enzyme ligation methods, as well as antibody conjugation using AJICAP® technology. In this presentation, we will introduce our one-stop-shop service from strain development to GMP manufacturing for client needs using our proprietary technologies. |
| Date, Time and Venue | April 10(Thu.) 14:00-14:30 【Seminar Room 5A(East Hall5)／Seminar Room C8(608, Conference Tower)】 |
Biopharma Seminar
| Title and Presenters | “One-stop-shop service for peptide/protein manufacturing by AJINOMOTO’s unique expression platform technologies CORYNEX®” Kentaro Nakase, Bio-pharma services dept., Ajinomoto Co., Inc. |
|---|---|
| Executive Summary | CORYNEX® is Ajinomoto Co., Inc.’s proprietary protein secretion production technology using endotoxin-free microorganisms. It excels in producing high-purity, high-accumulation VHH, antibody-like proteins, and long-chain peptides, significantly improving productivity and reducing environmental impact compared to traditional platforms. Additionally, we have developed technology to incorporate non-natural amino acids. This presentation will introduce our one-stop-shop service, from strain construction to process development and GMP manufacturing. In this presentation, we will introduce our one-stop-shop service from strain development to GMP manufacturing for client needs using our proprietary technologies. |
| Date, Time and Venue | April 11(Fri.)14:00-14:30 【Seminar Room 5A(East Hall5)／Seminar Room C8(608, Conference Tower)】 |